predisposition testing

predisposition testing

Susceptibility testing Analysis of testing of molecular markers to ID inherited mutations linked to CA–eg, inherited colorectal–MSH2, MSH1; breast–BRCA1, BRCA2; endocrine–RET, melanoma–p16; Li-Fraumeni syndrome–p53. See BRCA1, p16, p53, Tumor marker.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.
Mentioned in ?
References in periodicals archive ?
The Global genetic testing market is categorized based on application into Cancer Testing, Pharmacogenomics testing, Prenatal testing and Predisposition testing. Based on type of tests, the market is segmented into Carrier Testing, Diagnostic Testing, Prenatal Testing and Neonatal Testing.
** Predisposition testing, to determine if a person is at higher risk of developing a particular disease later in life
The genetic predisposition testing is a part of Test Diagnostics Genetic Health line of tests.
M2 PHARMA-August 10, 2010-Cord Blood America to sell DNA Predisposition testing services(C)2010 M2 COMMUNICATIONS
For other genetic tests, a result conferring risk might come with few recommendations proven to prevent the onset or progression of disease--a particularly controversial example of this is Alzheimer's disease predisposition testing. Without available risk-reducing measures, the utility of genetic testing is questionable, although some feel that testing allows better preparations for the future.
For other genetic tests, a result conferring risk might come with few recommendations proven to prevent the onset or progression of disease; a particularly controversial example of this is Alzheimer's disease predisposition testing. Without available risk-reducing measures, the utility of genetic testing is questionable, although some feel that testing allows better preparations for the future.
And as nucleic acid testing's potential is further realized for pharmacogenomics, including companion diagnostics, predisposition testing and therapeutic and targeted monitoring, the relationship between research and diagnostics platforms will grow closer, benefiting those companies that participate in both markets.
This requires a concomitant evolution towards payment by insurance companies and Medicare for predisposition testing related to prevention.
Finally, I very much appreciated the fact that the editors chose to include a chapter (chapter 21) on genetic counseling for hereditary cancer predisposition testing. Although not strictly a diagnostic procedure and thus often overlooked by the laboratory professional, such counseling is nevertheless an important issue and rightfully holds a place in the diagnostic continuum.
Genetic predisposition testing for cancer: Effects on families' lives.
"Because many important genetic diseases, such as Hereditary Hemochromatosis or cystic fibrosis, involve complex mutational analyses, we believe our technology platform is ideally suited to the expansion of genetic predisposition testing, which continues to grow due to the increasing amounts of genetic information from the Human Genome Project and other related efforts."
Until the network is implemented, the Cancer Genetics Studies Consortium, a group of researchers studying the social and psychological effects of predisposition testing, has convened a task force to evaluate currently used surveillance and treatment options for people with a known cancer susceptibility.[34]